CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • #AACR16 Update: Combination Therapies to Improve Anti-cancer Immune Responses

    Complementary treatments can help overcome resistance to immunotherapy.

    April 18, 2016| Arthur N. Brodsky, PhD
  • #AACR16 Update: Engaging the Immune System to Treat Pancreatic Cancer

    Immunotherapy strategies to treat pancreatic cancer could also be effective in other difficult-to-treat cancers.

    April 18, 2016| Arthur N. Brodsky, PhD
  • #AACR16 Update: Checkpoint Inhibition and Improving Anti-Tumor Immunity

    Releasing the brakes on the immune system to overcome cancer

    April 17, 2016| Arthur N. Brodsky, PhD
  • #AACR16 Update: Deciphering the Cancer Genome & Developing Tailored Treatments

    To conquer cancer, scientists must first unmask its identity

    April 17, 2016| Arthur N. Brodsky, PhD
  • Watching AACR from Near and Far

    Social media added a new dimension to the conversation at AACR.

    April 24, 2015| Emily Helck
  • AACR 2015: Report from Day 5

    Some lesser-known cell types in the immune response to cancer were discussed on the meeting's final day.

    April 22, 2015| Matthew Tontonoz
  • AACR 2015: Report from Day 4

    Spotlight on CAR T cell therapy.

    April 21, 2015| Matthew Tontonoz
  • AACR 2015: Report from Day 3

    Results of two high-profile clinical trials, among others, are covered on the meeting's third day.

    April 20, 2015| Matthew Tontonoz
  • AACR 2015: Report from Day 2

    Our report on the latest developments in cancer immunotherapy from day 2 at the annual AACR meeting…

    April 19, 2015| Matthew Tontonoz
Previous Page
1 2 3 4 5
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute